Current stage-Stage III Posts on Medivizor
Navigation Menu

Current stage-Stage III Posts on Medivizor

Ipilimumab vs high dose interferon for high risk melanoma

Posted by on Feb 15, 2020 in Melanoma | 0 comments

In a nutshell This study wanted to find out which was the better treatment for advanced melanoma that has been surgically treated, ipilimumab (Yervoy) or high dose interferon alfa (HDI). The study found that low dose ipilimumab resulted in better overall survival than HDI and high dose ipilimumab, but all of the treatments had...

Read More

Are abdominal infections a prognostic factor for recurrence after colorectal cancer surgery?

Posted by on Jan 26, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether tummy infections (TIs) after surgery are associated with colorectal cancer outcomes. Researchers suggested that TIs might be associated with a shorter time until recurrence. Some background Colorectal cancer is a common cancer in the US affecting more than 145,000 people every year. Surgery is...

Read More

Durvalumab after chemoradiotherapy for non-small cell lung cancer: analysis from the patients’ perspective

Posted by on Dec 23, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated the patient-reported outcomes after treatment with durvalumab (Imfinzi) for stage III non-small-cell lung cancer (NSCLC) that cannot be surgically removed. This study concluded that durvalumab did not affect the quality of life of these patients. Some background NSCLC is the most common form of lung cancer...

Read More

Complete mesocolic excision reduces the risk of recurrence in patients with colon cancer

Posted by on Dec 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of complete mesocolic excision (CME) in patients with right-side colon cancer. Researchers suggested that CME reduces the risk of recurrences (when cancer comes back) in these patients. Some background Colorectal cancer is one of the most common cancers worldwide. The standard treatment is surgery and...

Read More

Radiation therapy after surgery improves survival of patients with advanced colon cancer

Posted by on Dec 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of radiation therapy (RT) after surgery in patients with T4 (cancer that has grown outside of the colon outer layer and invades the surrounding tissues) colon cancer. Researchers suggested that RT improved overall survival in these patients. Some background Colorectal cancer is the third...

Read More

Evaluating the outcomes of patients with advanced melanoma with different treatments

Posted by on Dec 7, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out how well patients with advanced melanoma treated with certain medications survived outside of clinical trials. The study found that patients treated with nivolumab (Opdivo) and ipilimumab (Yervoy) or patients treated with anti-PD1 antibodies had longer survival compared to those treated with BRAF/MEK...

Read More

Chemotherapy improves survival of patients with mucinous colorectal adenocarcinoma

Posted by on Dec 7, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of chemotherapy on the survival of patients with stage 2 and 3 mucinous colorectal cancer (mucCRC). Researchers suggested that chemotherapy improved the survival of these patients. Some background Colorectal cancer is the third most common cancer in the US in 2019. Up to 20% of colon cancer is mucCRC....

Read More

Looking for patients with advanced triple negative breast cancer to test an experimental drug with three functions

Posted by on Oct 31, 2019 in Breast cancer | 0 comments

In a nutshell This trial is examining the safety and effectiveness of experimental drug mRNA-2752 in patients with advanced triple-negative breast cancer. The main outcome of the trial will be the number of side effects experienced by patients and response to treatment. This trial is recruiting in the United States and Israel. The details...

Read More

Looking for postmenopausal women with advanced breast cancer to try a hormonal therapy

Posted by on Oct 24, 2019 in Breast cancer | 0 comments

In a nutshell This study is looking for postmenopausal patients with advanced breast cancer with an ESR1 mutation to compare lasofoxifene (Fablyn) to fulvestrant (Faslodex). The main outcome measured in this trial will be the patient’s survival without tumor growth or spread. This trial is recruiting in multiple locations in the United...

Read More